Merck & Co Inc said it would sell its consumer care business to Germany's Bayer AG for $14.2 billion. Merck said it expects after-tax proceeds of between $8 billion and $9 billion from the sale.The deal is expected to close in the second half of 2014.
Merck & Co., Inc. (Merck) is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. Shares of MRK traded higher by 0.7% or $0.41/share to $58.63. In the past year, the shares have traded as low as $44.62 and as high as $59.84. On average, 11132100 shares of MRK exchange hands on a given day and today's volume is recorded at 8135606.
Source
